Anti-leukaemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on subline

This publication has 14 references indexed in Scilit:

• Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia
  Cancer Chemotherapy and Pharmacology, 1991
• Antitumour properties of dimethylsulphoxide ruthenium(II) complexes in the Lewis lung carcinoma system
  Pharmacological Research, 1989
• New Ruthenium Complexes for the Treatment of Cancer
  Published by Springer Nature ,1989
• Cis- and trans-dihalotetrakis(dimethyl sulfoxide)ruthenium(II) complexes (RuX2(DMSO)4; X = Cl, Br): synthesis, structure, and antitumor activity
  Inorganic Chemistry, 1988
• Reaction of cis-RuII(DMSO)4Cl2 with DNA and with some of its bases in aqueous solution
  Inorganica Chimica Acta, 1987
• Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms
  European Journal of Cancer and Clinical Oncology, 1984
• Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichlorodiammino platinum(II) in mice bearing Lewis lung carcinoma
  Chemico-Biological Interactions, 1983
• Mutagenic activity of platinum and ruthenium complexes
  Chemico-Biological Interactions, 1975
• Effects of cis -Dichlorodiammineplatinum (II) and Related Transition Metal Complexes on Escherichia coli
  Antimicrobial Agents and Chemotherapy, 1975
• Studies on the antitumor activity of group VIII transition metal complexes. Part I. Platinum (II) complexes
  Bioinorganic Chemistry, 1973